Fibrin subunits in venous and arterial thromboembolism

Cardiovascular Research

Volumn 10, Issue 4, 1976, Pages 421-426

  Gaffney, P J ^c   Brasher, M ^c   Lord, K ^a   Strachan, C J L ^a   Wilkinson, A R ^a   Kakkar, V V ^b   Scully, M F ^b  

^a CITY HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN;

BLOOD CLOT LYSIS; CYTOLOGY; EMBOLISM; ETIOLOGY; THROMBOSIS;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; IMMUNOELECTROPHORESIS, TWO-DIMENSIONAL; MOLECULAR WEIGHT; PEPTIDES; PLASMIN; PULMONARY EMBOLISM; THROMBOEMBOLISM; THROMBOPHLEBITIS;

EID: 0017068916     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/10.4.421     Document Type: Review

References (26)

1. Chen, R., and Doolittle, R. F. (1970). Isolation, characterization and location of a donor-acceptor unit from cross-linked fibrin. Proceedings of the National Academy of Sciences, 66, 472–479.
2. Clarke, H. G. M., and Freeman, T. (1968). Quantitative Immunoelectrophoresis of human serum proteins. Clinical Science, 35, 403–413.
3. Eie, H., Amundsen, E., and Ra, J. S. (1972). Thrombolytic treatment with Brinase of dogs with experimental pulmonary embolism. Scandinavian Journal of Thoracic and Cardiovascular Surgery, 6, 164–171.
4. Finlayson, J. S., and Aronson, D. L. (1974). Crosslinking of rabbit fibrin in vivo. Thrombosis el Diathesis Haemorrhagi-ca, 31, 435–438.
5. Finlayson, J. S., Mosesson, M. W., Bronzert, T. J., and Pis-ano, J. T. (1972). Human fibrinogen heterogeneities. II. Crosslinking capacity of high solubility catabolic intermediates. Journal of Biological Chemistry, 247, 5220–5222.
6. Frisch, E. P. (1972). Thrombolytic experience with brinase. Clinical experience with brinase. Journal of Clinical Pathology, 25, 653–654.
7. Frisch, E. P., and Fitzgerald, D. E. (1973). Relief of chronic peripheral artery obstruction by intravenous Brinase. Journal of the Irish Medical Association, 66, 313–318.
8. Gaffney, P. J. (1972). Localization of carbohydrate in the subunits of human fibrinogen and its plasmin induced fragments. Biochimica et Biophysica Acta, 263, 453–458.
9. Gaffney, P. J. (1973). Subunit relationships between fibrinogen and fibrin degradation products. Thrombosis Research, 2, 201–218.
10. Gaffney, P. J. (1975). Molecular pathology of the multiple forms of fibrinogen and its fragments. In Isozymes. II. Physiological Function, ed. by C. L. Markert, pp. 343–368. Academic Press: London.
11. Gaffney, P. J., and Brasher, M. (1973). Subunit structure of the plasmin-induced degradation products of crosslinked fibrin. Biochimica et Biophysica Acta, 295, 308–313.
12. Gaffney, P. J., Chesterman, C. N., and Allington, M. J. (1974). Plasma fibrinogen and its fragments during streptokinase treatment. British Journal of Haematology, 26, 285–293.
13. Gaffney, P. J., and Dobos, P. (1971). A structural aspect of human fibrinogen suggested by its plasmin degradation. FEBS Letters, 15, 13–16.
14. Gaffney, P. J., Lane, D. A., and Brasher, M. (1975a). Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of crosslinked human fibrin. Clinical Science and Molecular Medicine, 49, 149–156.
15. Gaffney, P. J., Lord, K., and Thornes, R. D. (1975b). The action of Brinase in vitro and in vivo. Thrombosis et Diathesis Haemorrhagica, 34, 914.
16. McDonagh, R. P., McDonagh, J., and Duckert, F. (1971). The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis. British Journal of Haematology, 21, 323–332.
17. McKee, P. A., Mattock, P., and Hill, R. L. (1970). Subunit structure of human fibrinogen, soluble fibrin and cross linked insoluble fibrin. Proceedings of the National Academy of Sciences, 66, 738–744.
18. Marder, V. J., Shulman, N. R., and Carroll, W. R. (1969). High molecular weight derivatives of human fibrinogen produced by plasmin. 1. Physicochemical and immunological characterization. Journal of Biological Chemistry, 244,2111–2119.
19. Nussenzweig, V., Seligmann, M., Pelmont, J., and Grabar, P. (1961). Les produits de degradation du fibrinogene humain par la plasmine. 1. Separation et proprietes physico-chimiques. Annates de I’lnstitut Pasteur, 100, 377–389.
20. Pisano, J. J., Bronzert, T. J., Peyton, M. P., and Finlayson, J. S. (1972). Epsilon-(gamma-glutamyl) lysine crosslinks: determination in fibrin from normal and Factor XIII-deficient individuals. Annals of the New York Academy of Sciences, 202, 98–113.
21. Pizzo, S. V., Taylor, L. M., Jr, Schwartz, M. L., Hill, R. L., and McKee, P. A. (1973). Subunit structures of fragment D from fibrinogen and crosslinked fibrin. Journal of Biological Chemistry, 248, 4584–4590.
22. Sharp, A. A., and Chesterman, C. N. (1972). Problems related to fibrinolysis. Journal of Clinical Pathology, 25, 613.
23. Sherry, S., Fletcher, A. P., and Alkjaersig, N. (1959). Fibrinolysis and fibrinolytic activity in man. Physiological Reviews, 39, 343–382.
24. Strachan, C. J. L., GafTney, P. J., Scully, M. F., and Kakkar. V. V. (1974). An experimental model for the study of venous thrombosis in vivo. Thrombosis Research, 5, 235–242.
25. Weber, K., and Osborn, M. (1969). The reliability of molecular weight determinations by dodecyl sulphate poly-acrylamide gel electrophoresis. Journal of Biological Chemistry, 244, 4406–4412.
26. Zacharius, R. M., Zell, T. E., Morrison, J. H., and Wood-lock, J. J. (1969). Glycoprotein staining following electrophoresis on acrylamide gels. Analytical Biochemistry, 30, 148–152.